EIF2AK1

Chr 7AD

eukaryotic translation initiation factor 2 alpha kinase 1

Also known as: HCR, HRI, hHRI

EIF2AK1 encodes a metabolic stress-sensing kinase that phosphorylates eukaryotic translation initiation factor 2 alpha in response to heme deficiency, oxidative stress, and mitochondrial dysfunction, thereby regulating protein synthesis and cellular stress responses. Mutations cause leukoencephalopathy, motor delay, spasticity, and dysarthria syndrome with autosomal dominant inheritance. The gene is highly constrained against loss-of-function variants (LOEUF 0.71), indicating that such variants are likely pathogenic.

OMIMResearchSummary from RefSeq, OMIM, UniProt
MultiplemechanismADLOEUF 0.711 OMIM phenotype
Clinical SummaryEIF2AK1
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
46 unique Pathogenic / Likely Pathogenic· 219 VUS of 413 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.71LOEUF
pLI 0.000
Z-score 2.89
OE 0.47 (0.320.71)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
0.43Z-score
OE missense 0.93 (0.851.02)
312 obs / 334.4 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.47 (0.320.71)
00.351.4
Missense OE0.93 (0.851.02)
00.61.4
Synonymous OE1.08
01.21.6
LoF obs/exp: 16 / 34.2Missense obs/exp: 312 / 334.4Syn Z: -0.69
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
limitedEIF2AK1-related neurodevelopmental syndromeOTHERAD
DN
0.75top 25%
GOF
0.6443th %ile
LOF
0.3357th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

413 submitted variants in ClinVar

Classification Summary

Pathogenic42
Likely Pathogenic4
VUS219
Likely Benign85
Benign19
Conflicting3
42
Pathogenic
4
Likely Pathogenic
219
VUS
85
Likely Benign
19
Benign
3
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
2
0
40
0
42
Likely Pathogenic
1
0
3
0
4
VUS
11
176
29
3
219
Likely Benign
1
5
28
51
85
Benign
0
5
9
5
19
Conflicting
3
Total1518610959372

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

EIF2AK1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →